Recent 8-K filings for ASPC
Highest-materiality recent filing
A SPAC III gets Nasdaq deficiency notice for equity below $2.5M minimum
- Received Nasdaq letter on May 20, 2026 citing stockholders' equity < $2.5M minimum.
- Must submit compliance plan within 45 days; Nasdaq may grant up to 180-day extension.
-
A SPAC III gets Nasdaq deficiency notice for equity below $2.5M minimum
Received Nasdaq letter on May 20, 2026 citing stockholders' equity < $2.5M minimum.
-
ASPAC III shareholders approve extension to Nov 2026; ~5.7M shares redeemed
Charter amended to extend deadline for business combination from Nov 12, 2025 to Nov 12, 2026.
-
ASPAC III Acquisition Corp. enters $200M all-stock merger with Bioserica International
Aggregate consideration of $200M payable entirely in Purchaser Class A and Class B ordinary shares at $10.00 per share.
-
ASPAC III Acquisition Corp. announces $200M all-stock acquisition of Bioserica International
Agrees to acquire Bioserica International, a bio-based antimicrobial materials company, for $200M in stock at $10.00/share.
-
A SPAC III Acquisition Corp. signs non-binding $300M stock deal for HDEducation Group
Reincorporation merger creates new BVI parent; then subsidiary merges into HD Group, making it a wholly owned subsidiary.
-
A SPAC III Acquisition Corp. closes $55M IPO; auditor flags going concern risk
IPO of 5,500,000 units at $10/unit closed Nov 12, 2024; gross proceeds of $55M deposited in trust.
-
A SPAC III Acquisition Corp. closes $55M IPO; trust funded with $55M
Sold 5,500,000 units at $10.00/unit, raising $55,000,000 gross proceeds.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.60 · Most common event other_material